Rishabh Instruments Limited
NSE: RISHABHMarket Closed • NSE
Day range
52 week range
Rishabh Instruments Limited closed at INR677.90 (+5.12%) on volume 4.03x its 20-day average, trading 20.43% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -5% QoQ
2026-07-24
DIVIDEND Announced
Dividend - Rs 2 Per Sh
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.11x
High Cash Flow Conversion: CFO/PAT averaged 1.51x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Scientific & Technical Instruments.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 24 Jul 2026 | Dividend | ₹2.00 / share | — | 24 Jul 2026 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Tata Consultancy Services LimitedTCS Open analysis | ₹7.80L | 15.66 | 2.31% | ₹72,275.00 | ₹13,420.00 | +13.93% | +4.69% |
 Infosys LimitedINFY Open analysis | ₹4.15L | 13.94 | 5.02% | ₹48,211.00 | ₹7,775.00 | +14.03% | +12.29% |
 HCL Technologies LimitedHCLTECH Open analysis | ₹3.29L | 18.93 | 5.10% | ₹34,579.00 | ₹4,626.00 | +13.94% | +20.34% |
 Wipro LimitedWIPRO Open analysis | ₹1.61L | 12.91 | 5.05% | ₹24,236.30 | ₹3,501.80 | +7.70% | -1.90% |
 Tech Mahindra LimitedTECHM Open analysis | ₹1.34L | 26.18 | 3.41% | ₹15,712.00 | ₹1,486.00 | +17.68% | +31.62% |
 LTM LimitedLTM Open analysis | ₹1.21L | 23.09 | 1.92% | ₹11,608.00 | ₹1,469.00 | +17.96% | +17.05% |
 LG ELECTRONICS INDIA LTDLGEINDIA Open analysis | ₹1.19L | 65.34 | 0.00% | ₹7,233.35 | ₹652.86 | — | — |
 One97 Communications LimitedPAYTM Open analysis | ₹1.05L | 163.44 | 0.00% | ₹2,264.00 | ₹184.00 | +18.41% | +134.07% |
Rishabh Instruments limited, with an experience of nearly three decades is an organization that has built its core competence in manufacturing, design and development of Test and Measuring Instruments and Industrial Control Products on strong fundamentals; in terms of people, infrastructure and financials. The company provides a hands-on, value driven, professional environment considering people its most important asset.[1]
IndiaTechnology
Is Rishabh Instruments Limited Shariah compliant?
Rishabh Instruments Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (3.07%) complies with AAOIFI threshold (≤ 33%).
What is Rishabh Instruments Limited's current valuation relative to peers?
Rishabh Instruments Limited trades at a P/E of 32.4x compared to the sector median of 22.8x, and a Price-to-Book of 3.5x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.11x. Interest coverage is 16.5x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at 2.7% while net profit growth averaged 15.5%.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.